Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Stage 2 proposal H2020 PHC13

Reference number
Coordinator Annexin Pharmaceuticals AB
Funding from Vinnova SEK 150 000
Project duration May 2014 - August 2014
Status Completed

Last updated 25 November 2019

Reference number 2014-03599

Page statistics